A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

By Rösler Michael   Fischer Roland   Ammer Richard   Ose Claudia   Retz Wolfgang  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 120-129

Springer Publishing Company

Access to resources Recommend Favorite

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

By Aron A.R.   Dowson J.H.   Sahakian B.J.   Robbins T.W.  

Biological Psychiatry, Vol. 54, Iss. 12, 2003-12 ,pp. : 1465-1468

Elsevier

Access to resources Recommend Favorite

Attention deficit hyperactivity disorder in adults-early vs. late onset in a retrospective study

By Hesslinger B.   Tebartz van Elst L.   Mochan F.   Ebert D.  

Psychiatry Research, Vol. 119, Iss. 3, 2003-08 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Methylphenidate-induced improvements of various measures of attention in adults with Attention Deficit Hyperactivity Disorder

By Tucha O.   Mecklinger L.   Laufkötter R.   Klein H. E.   Walitza S.   Lange K. W.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1575-1592

Springer Publishing Company

Access to resources Recommend Favorite

Do the beneficial effects of extended methylphenidate treatment in boys with attention-deficit hyperactivity disorder dissipate rapidly during placebo treatment?

By  

Nordic Journal of Psychiatry, Vol. 53, Iss. 1, 1999-03 ,pp. : 55-60

Informa Healthcare

Access to resources Recommend Favorite